CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue meaning it stimulates the pituitary to release growth hormone with fewer off-target effects than older compounds
It also functions as an anti-inflammatory and antioxidant substance, which may decrease the damage that exercise causes to the muscles [2]
Patients beginning at higher body weights often see faster initial loss (10-20 pounds in first 3 months) compared to those closer to goal weight (5-8 pounds in 3 months)
dose-for-dose equivalence is not 1:1
With respect to cognitive function, choline is needed for myelination of nerves and is a precursor for acetylcholine an important neurotransmitter involved in muscle action, memory, and other functions
While GLP-1 and shortness of breath are not typically linked in FDA prescribing information, some patients report respiratory symptoms during treatment